| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |